About Univ. Clinic Hosp, Bialystok
Uniwersytet Medyczny w Białymstoku – publiczna uczelnia o profilu medycznym powstała 3 lutego 1950 roku. Siedzibę Uniwersytetu stanowi spalony w czasie wojny, a następnie odbudowany pałac Branickich.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
8
Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań
1
Clovis Oncology, Inc.
1
Polish Adult Leukemia Group
1
University Hospital, Toulouse
1
Clinical Trials at Univ. Clinic Hosp, Bialystok
During the past decade, Univ. Clinic Hosp, Bialystok conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
2012-08-22
2019-12-13
Completed
10,471
Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
2014-05-06
2016-10-20
Completed
503
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
2014-07-22
2017-06-05
Completed
2,725
Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
2016-05-16
2020-08-18
Completed
121
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old
2017-07-03
2022-12-31
Recruiting
582
An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis
2018-01-09
2021-07-27
Completed
69
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Univ. Clinic Hosp, Bialystok" #1 sponsor was "Boehringer Ingelheim" with 8 trials, followed by "Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań" with 1 trials
sponsored, "Clovis Oncology, Inc." with 1 trials sponsored, "Polish Adult Leukemia Group" with 1 trials sponsored and "University Hospital, Toulouse"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Univ. Clinic Hosp, Bialystok"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Univ. Clinic Hosp, Bialystok
According to Clinical.Site data, the most researched conditions in "Univ. Clinic Hosp, Bialystok" are
"Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Lupus Nephritis" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Angioplasty" (1 trials). Many other conditions were trialed in "Univ. Clinic Hosp, Bialystok" in a lesser frequency.
Clinical Trials Intervention Types at Univ. Clinic Hosp, Bialystok
Most popular intervention types in "Univ. Clinic Hosp, Bialystok" are "Drug" (10 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (3 trials), "A arm (CLAG-M)" (1 trials), "A arm (DA-90)" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Univ. Clinic Hosp, Bialystok
The vast majority of trials in "Univ. Clinic Hosp, Bialystok" are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Univ. Clinic Hosp, Bialystok
Currently, there are NaN active trials in "Univ. Clinic Hosp, Bialystok".
1 are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Univ. Clinic Hosp, Bialystok,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Univ. Clinic Hosp, Bialystok, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".